Navigating the path to medical device certification europe is more complex than ever. The shift to the EU Medical Device Regulation (MDR 2017/745) and the In Vitro Diagnostic Regulation (IVDR 2017/746) has introduced stricter rules for safety, performance, and transparency. Achieving EU MDR compliance or IVDR compliance is no longer just about filling out forms; it requires a continuous lifecycle approach, clinical evidence, and technical documentation. That is where we step in. As your dedicated EU MDR consultant, Morulaa Health Tech does more than just write your documents; we engineer your submission for first-time success.

Why Partner With an Expert EU MDR Consultant? The 80% Advantage

We do not just hand you a technical file and walk away. Morulaa Health Tech becomes an extension of your project team, managing the documentation and the Notified Body submission from start to finish. Here is what makes our approach effective:

• Actionable Intelligence Across NBs: We actively track the latest trends in questions and non-conformities (NCs) across multiple Notified Bodies.

• Proactive File Optimization: We apply this cross-industry intelligence to your files before submission, preemptively addressing the gaps that NBs are currently scrutinizing to maintain EU MDR or EU IVDR compliance.

• Specialized Writing Teams: We utilize specialist writers who focus on specific sections, ensuring expert-level depth in risk management, clinical evaluation, technical documentation, labelling etc

Proven Results: Companies that partner with an experienced EU MDR consultant typically experience 80% fewer non-conformities compared to handling submissions alone.

Morulaa Health Tech  End-to-End Compliance for Medical Device Registration in EU

Our team provides support for both medical devices and in vitro diagnostics for medical device registration in the EU. Without proper CE marking, your medical device cannot be legally sold in the EU market.

Technical Documentation Preparation by Your EU MDR consultant

We build and compile detailed technical files that serve as the proof of your device's safety and performance.

• MDR Requirements: We structure documentation according to Annex II and III, covering device description, risk management results, and clinical evidence to secure EU MDR compliance.

• IVDR Requirements: We develop the Performance Evaluation Reports as a part of the key evidence across scientific validity and clinical performance for maintaining EU IVDR compliance.
  
  

MDD to MDR Transition for Legacy Devices

Older devices previously cleared under older directives must be upgraded to meet the new, stricter regulatory frameworks.

• MDD to MDR Transition: We conduct gap assessments on your existing technical files and quality systems, updating clinical evaluations and post-market surveillance (PMS) plans to meet MDR standards.

• IVDD to IVDR Transition: We help you navigate the shift to the new risk-based classification system. We upgrade your documentation to survive this new level of scrutiny during the IVDD to IVDR Transition.

Efficient NC Remediation and EU MDR Compliance

At Morulaa, we specialize in remediating Notified Body non-conformities by addressing technical deficiencies into Technical Documentation that meets the auditors interpretation of the EU MDR (2017/745) and IVDR (2017/746). Examples include

• Establishing Traceability: We resolve deficiencies in GSPR compliance by creating Traceability Matrices. We verify if every hazard identified in your ISO 14971 Risk Management File - such as overcurrent or cross-contamination—is linked to specific design mitigations, EN 62366-1 Usability summative evaluations, and corresponding clinical performance objectives.

• Biological & Material Safety (Annex II): We analyse NCs regarding CMR substances (like Cobalt) and phthalates. Ex: Morulaa assists in documenting disclosed concentrations and conducting toxicological risk assessments to satisfy GSPR 10.4.1, so that the Biological Evaluation Plan (BEP) aligns with ISO 10993-1.

• Clinical Evidence Remediations: We bridge the gap between the CEP and CER. For legacy or equivalent devices, we strengthen the "equivalence" argument under Annex XIV, Article 61 (10) mapping clinical or preclinical data to measurable performance and safety endpoints while justifying the Benefit-Risk Ratio based on the current State of the Art (SotA).

• Lifecycle & Verification Consistency: We identify discrepancies between Shelf-Life data, Accelerated Aging (ASTM F1980), and labelling. Whether it is justifying statistically significant sample sizes or that the eIFU complies with Regulation 2021/2226, we verify if all data points are uniform across your Technical File.

By acting as your EU IVDR or EU MDR Consultant we are able to do the remediation of the documents to address the Notified Body's queries to help you get EU MDR approved or EU IVDR approved for successful CE Marking.

Secure Market Access via the Best EU MDR Consultant

Do not let documentation gaps or unexpected Notified Body questions stall your product launch. By partnering with Morulaa Health Tech, you leverage shared industry intelligence to streamline your path to CE marking.

Our MDD to MDR transition / IVDD to IVDR transition services help your legacy products remain on the market. Achieving long-term EU MDR compliance requires a proactive strategy. Contact our EU MDR Consultant team today to discuss your medical device / IVDD registration in EU goals or your final MDD to MDR transition strategy.

Frequently Asked Questions (FAQs) on EU MDR / IVDR Compliance